- not yet recruitingPHASE3
Optimizing the Use of Aspirin for the Prevention of Preeclampsia
This study looks at whether pregnant women at high risk of pre-eclampsia can safely stop taking low-dose aspirin earlier. It compares stopping aspirin at 24-28 weeks of pregnancy with continuing until 36 weeks, to see if shorter treatment is just as effective.
Austria · Bulgaria · Ghana - recruiting
Hyperspectral Imaging for Prediction of Preeclampsia
This study looks at a new, gentle scanning method to predict pre-eclampsia in pregnant women. It checks tiny blood vessels to see if changes could show who might get this serious pregnancy condition. The aim is to help doctors spot it early.
Germany - recruiting
Berlin-Brandenburg Pregnancy Cohort
This study looks at how immune cells and placenta cells work together in pregnant women. Researchers want to understand why some women get conditions like pre-eclampsia or diabetes during pregnancy, and how these conditions might affect the mother's heart and blood vessels.
Germany - ongoing, recruitingTherapeutic confirmatory (Phase III)
A prospective interventional randomized controlled trial to assess the effect of low dose acetylsalicylic acid as a preventive treatment of preeclampsia in pregnant women who underwent frozen embryo transfer
This study is looking at whether a low dose of aspirin can help prevent a pregnancy complication called pre-eclampsia in women who've had frozen embryo transfer. It compares aspirin to no aspirin to see if it makes a difference.
Belgium